amiodarone has been researched along with Pneumonia, Lipid in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Pneumonia, Lipid: Pneumonia due to aspiration or inhalation of various oily or fatty substances.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 7.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "To investigate any relationship between the pathological features of amiodarone-induced pulmonary toxicity (APT) and clinical use of amiodarone in patients dying from acute respiratory distress syndrome (ARDS)." | 3.70 | Acute amiodarone-induced lung toxicity. ( Donaldson, L; Grant, IS; Naysmith, MR; Thomas, JS, 1998) |
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 3.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "Diagnosis of extrinsic allergic alveolitis is based on the association of clinical, radiological, functional, immunological criteria and bronchoalveolar lavage fluid analysis." | 2.41 | [Diffuse infiltrative lung diseases due to allergy and iatrogenic causes]. ( Dalphin, JC, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa-Jussà , FR | 1 |
| Corrin, B | 1 |
| Jacobs, JM | 1 |
| Donaldson, L | 1 |
| Grant, IS | 1 |
| Naysmith, MR | 1 |
| Thomas, JS | 1 |
| Dalphin, JC | 1 |
| Clarke, B | 1 |
| Ward, DE | 1 |
| Honey, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for amiodarone and Pneumonia, Lipid
| Article | Year |
|---|---|
[Diffuse infiltrative lung diseases due to allergy and iatrogenic causes].
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Cr | 2000 |
3 other studies available for amiodarone and Pneumonia, Lipid
| Article | Year |
|---|---|
Amiodarone lung toxicity: a human and experimental study.
Topics: Adult; Amiodarone; Animals; Benzofurans; Humans; Lung; Lung Neoplasms; Lymphatic Diseases; Male; Mic | 1984 |
Acute amiodarone-induced lung toxicity.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Databases, Factu | 1998 |
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Benzofurans; Combined Modality Therapy; Exer | 1985 |